Clinical Trial Detail

NCT ID NCT02444793
Title A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements no
Sponsors Pfizer
Indications

colorectal cancer

bladder carcinoma

lung squamous cell carcinoma

ovarian carcinoma

head and neck squamous cell carcinoma

Advanced Solid Tumor

Therapies

Mogamulizumab + Utomilumab

Age Groups: adult senior

No variant requirements are available.